CryoFuture secures investment for growth

CryoFuture, a fertility specimen storage and transport company, has secured investment from a Chicago-based family office-backed firm.

The San Mateo-based company runs seven fertility-dedicated storage sites across the US and provides cryogenic transport services (moving biological materials at ultra-low temperatures) for IVF clinics and patients.

CryoFuture was founded by senior embryologist Sean Pae and healthcare executive Cherie Kloss.

The company said the funding will support national expansion and continued investment in its cryopreservation technology (preserving cells and tissues at very low temperatures) and services.

Sean Pae, founder and chief executive of CryoFuture, said: “Safe, secure, and convenient long-term cryopreservation is essential for IVF clinics and patients, and we are proud to lead with the most comprehensive suite of services.

“The Liss Capital partnership validates the progress we’ve made in bringing local, long-term storage solutions to fertility clinics and patients across the US and enables us to scale responsibly while continuing to deliver the white-glove service the IVF community deserves.”

The investment was from Liss Capital Partners. The companies did not disclose the investment amount.

Cameron Liss, co-managing partner of Liss Capital Partners, said: “CryoFuture is redefining the way fertility specimens are safeguarded in the US.

“Its infrastructure, technology, and service model set a new benchmark for mission-critical cryopreservation.

“We are proud to partner with a category leader and look forward to helping accelerate CryoFuture’s continued expansion as clinics and patients increasingly seek safer, more transparent, and more reliable solutions.”